ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice - PubMed (original) (raw)

ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice

Javier S Burgos et al. J Neurovirol. 2006 Dec.

Abstract

Herpes simplex virus type 1 (HSV-1) expresses an immediate-early protein, ICP47, that blocks the major histocompatibility complex class I antigen presentation pathway by binding to the transporter associated with antigen presentation (TAP). The result is the virus' evasion of the immune system. Although the interaction between ICP47 and TAP has been examined in vitro, this paper is the first to report their interaction in vivo. In C57BL/6 adult female mice, ICP47-defective virus (Delta ICP47, F strain) was less able to invade the organs studied than was wild-type HSV-1 F strain, showing that ICP47 influences general invasiveness. However, the neuroinvasiveness of the Delta ICP47 virus was recovered in TAP-deficient mice, indicating that the TAP-ICP47 interaction is specific to neural tissues. HSV-1 F strain showed no significant differences in their invasiveness in TAP-deficient and wild-type mice. Therefore, although ICP47 appears to be essential for invasion, the presence of TAP appears not to be crucial. Western blotting showed TAP1 expression to increase by at least fourfold in the brains and adrenal glands of infected mice. This suggests that TAP plays an important role in the host defense system. This increased expression may be particularly important in the encephalon since the baseline protein levels of this organ are low (ratio adrenal protein level/encephalon protein level > 100). However, Delta ICP47 virus provoked no significant increase in the brain TAP1 levels of wild-type mice because it could not invade this organ. These results suggest that ICP47 plays a role in infection, and that TAP1 production is regulated during viral challenge.

PubMed Disclaimer

Cited by

An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma.
Reale A, Gatta A, Shaik AKB, Shallak M, Chiaravalli AM, Cerati M, Zaccaria M, La Rosa S, Calistri A, Accolla RS, Forlani G. Reale A, et al. J Transl Med. 2024 Sep 27;22(1):862. doi: 10.1186/s12967-024-05650-5. J Transl Med. 2024. PMID: 39334370 Free PMC article.
The expression and function of HSV ICP47 and its promoter in mice.
Velusamy T, Singh N, Croft S, Smith S, Tscharke DC. Velusamy T, et al. J Virol. 2023 Nov 30;97(11):e0110723. doi: 10.1128/jvi.01107-23. Epub 2023 Oct 30. J Virol. 2023. PMID: 37902400 Free PMC article.
Broadly Antiviral Activities of TAP1 through Activating the TBK1-IRF3-Mediated Type I Interferon Production.
Zhao J, Li R, Li Y, Chen J, Feng F, Sun C. Zhao J, et al. Int J Mol Sci. 2021 Apr 28;22(9):4668. doi: 10.3390/ijms22094668. Int J Mol Sci. 2021. PMID: 33925089 Free PMC article.
"Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.
Dogrammatzis C, Waisner H, Kalamvoki M. Dogrammatzis C, et al. Viruses. 2020 Dec 23;13(1):17. doi: 10.3390/v13010017. Viruses. 2020. PMID: 33374862 Free PMC article. Review.
Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution.
Verweij MC, Horst D, Griffin BD, Luteijn RD, Davison AJ, Ressing ME, Wiertz EJ. Verweij MC, et al. PLoS Pathog. 2015 Apr 16;11(4):e1004743. doi: 10.1371/journal.ppat.1004743. eCollection 2015 Apr. PLoS Pathog. 2015. PMID: 25880312 Free PMC article. Review.

References

1. Neurobiol Aging. 2007 Apr;28(4):519-23 - PubMed
1. Clin Exp Immunol. 2000 Aug;121(2):173-8 - PubMed
1. Nature. 1994 Feb 17;367 (6464):648-51 - PubMed
1. EMBO J. 1996 Jul 1;15(13):3247-55 - PubMed
1. Mol Chem Neuropathol. 1996 May-Aug;28(1-3):135-41 - PubMed

ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice - PubMed (original) (raw)